Zdrowie i gospodarka · 11/07/2003

FDA Issues Advance Notice of Proposed Rulemaking on Trans Fatty Acids in Nutrition Labeling

The Food and Drug Administration (FDA) is issuing an advance notice of proposed rulemaking (ANPRM) to gather information and data on trans fatty acids, nutrient content claims, and health claims. The agency seeks comments on potential footnote or disclosure statements to help consumers make heart-healthy food choices.